FDA will no longer require significant warning label with hormone therapies for menopause

The U.S. Food and Drug Administration will remove the "black box" warning labels on many hormone therapy drugs used for menopause and perimenopause symptoms — a major turnaround that's likely to encourage more women to seek treatment. For video licensing inquiries, contact: [email protected]